NCT03630328

Angelica Gigas Dietary Supplements and Human Immune Cells

Study of Angelica Gigas Dietary Supplements (Cogni.Q) and Potential Effects on Human Immune Cells

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 15 (actual)
• Sponsor: Milton S. Hershey Medical Center · Academic / Other
• Sex: Male
• Age: 21 Years – 65 Years
• Healthy volunteers: Accepted

Summary

This human study will test the impact of dietary supplement vegicaps containing Korean Angelica root extract on 2 types of human immune cells: neutrophils that kill bacteria and other germs and natural killer (NK) cells that kill virus-infected cells and cancers. The investigators had done an earlier study with Korean Angelica supplement and discovered even a single dose of it increased blood neutrophils and NK cells within 24 h. In the new study, Korean Angelica capsules (Cogni.Q) will be compared head-to-head with dummy (placebo) capsules. This is to make sure the immune boosting actions are really from the Korean Angelica supplement.

Conditions

• Innate Immune Cells

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Cogni.Q	AGN
OTHER	Placebo	Placebo

Timeline

• Start date: 2019-02-06
• Primary completion: 2026-02-25
• Completion: 2026-02-25
• First posted: 2018-08-14
• Last updated: 2026-02-27

Locations

1 site across 1 country: United States